[HTML][HTML] A brief history of anti-VEGF for the treatment of ocular angiogenesis
LA Kim, PA D'Amore - The American journal of pathology, 2012 - Elsevier
The American journal of pathology, 2012•Elsevier
In 1994, The American Journal of Pathology published a key article reporting that hypoxic
retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in
ocular neovascularization. Subsequent developments in anti-VEGF treatment for
neovascular eye disease have improved visual outcomes and changed the standard of care
in retinal medicine and ophthalmology.
retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in
ocular neovascularization. Subsequent developments in anti-VEGF treatment for
neovascular eye disease have improved visual outcomes and changed the standard of care
in retinal medicine and ophthalmology.
In 1994, The American Journal of Pathology published a key article reporting that hypoxic retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in ocular neovascularization. Subsequent developments in anti-VEGF treatment for neovascular eye disease have improved visual outcomes and changed the standard of care in retinal medicine and ophthalmology.
Elsevier